Lori N. Griner, Ph.D.
Affiliations: | 2013 | Biology (Cell Biology, Microbiology, Molecular Biology) | University of South Florida, Tampa, FL, United States |
Area:
Molecular BiologyGoogle:
"Lori Griner"Parents
Sign in to add mentor| Gary W. Reuther | grad student | 2013 | University of South Florida | |
| (The Mevalonate Pathway: A Potential Therapeutic Target for JAK2-driven Myeloproliferative Neoplasms.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Basiorka AA, McGraw KL, De Ceuninck L, et al. (2016) Lenalidomide Stabilizes the Erythropoietin Receptor by Inhibiting the E3 Ubiquitin Ligase RNF41. Cancer Research |
| Mazzacurati L, Lambert QT, Pradhan A, et al. (2015) The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cells. Oncotarget |
| Griner LN, McGraw KL, Johnson JO, et al. (2013) JAK2-V617F-mediated signalling is dependent on lipid rafts and statins inhibit JAK2-V617F-dependent cell growth. British Journal of Haematology. 160: 177-87 |
| Basiorka AA, McGraw KL, Griner LN, et al. (2012) Lenalidomide Upregulates Erythropoietin Receptor Expression Through Inhibition of the E3-Ubiquitin Ligase Ring Finger Protein 41 (RNF41) Blood. 120: 3455-3455 |
| Griner LN, McGraw KL, Johnson JO, et al. (2011) A Mechanistic Rationale for the Use of Statins to Enhance JAK Inhibitor Therapy in MPNs Blood. 118: 2816-2816 |
| Griner LN, Reuther GW. (2010) Aggressive myeloid leukemia formation is directed by the Musashi 2/Numb pathway. Cancer Biology & Therapy. 10: 979-82 |
| Pradhan A, Lambert QT, Griner LN, et al. (2010) Activation of JAK2-V617F by components of heterodimeric cytokine receptors. The Journal of Biological Chemistry. 285: 16651-63 |
| Griner LN, McGraw KL, Johnson JO, et al. (2010) Requirement of Lipid Raft Integrity for Signaling by JAK2-V617F Blood. 116: 4191-4191 |
| Pradhan AR, Lambert QT, Griner LN, et al. (2009) Activation of JAK2-V617F by Heterodimeric Receptor Components. Blood. 114: 2955-2955 |